Labviva CEO Siamak Baharloo on Transforming Life Sciences Procurement with Innovation and AI

In a conversation with BioPharma BoardRoom, Siamak Baharloo, the visionary Co-founder and CEO of Labviva, delves into the transformative role of technology...

January 22, 2025 | Wednesday | Interview
Sotera Health Reports 5% Growth in 2024 Revenue, Provides Business Update at J.P. Morgan Healthcare Conference

 Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-...

January 15, 2025 | Wednesday | News
Driving the Future of Biopharma in 2025: How MoleculeAI is Shaping AI-Driven Drug Discovery

  In an interaction with BioPharma BoardRoom, Saurabh Singal, CEO & Founder of MoleculeAI, discusses how their generative AI-driven tools...

December 19, 2024 | Thursday | Interview
Innovating for Impact: Venkata Indurthi on Aldevron’s Vision for Biomanufacturing in 2025

  In a compelling conversation with BioPharma BoardRoom, Venkata Indurthi, Chief Scientific Officer at Aldevron, shares insights into the inn...

December 12, 2024 | Thursday | Interaction
Redefining Precision Medicine: Demaris Mills on IDT’s Role in Precision Medicine and Gene Synthesis for 2025

In a thought-provoking Q&A with BioPharma BoardRoom, Demaris Mills, President of Integrated DNA Technologies (IDT), discusses the transformative advanc...

December 12, 2024 | Thursday | Interaction
Shaping the Future of Gene Therapy: Kerstin Pohl on Analytical Innovations for 2025

In a detailed interview with BioPharma BoardRoom, Kerstin Pohl, Senior Global Marketing Manager for Gene Therapy & Nucleic Acid at SCIEX, delves into t...

December 12, 2024 | Thursday | Interaction
Gilead Sciences to Present Pivotal Research at The Liver Meeting® 2024

Gilead Sciences, Inc. (Nasdaq: GILD) announced new research to be presented at The Liver Meeting ® 2024, hosted by the American Association f...

October 23, 2024 | Wednesday | News
Biogen to Showcase Promising Data on Felzartamab at Kidney Week 2024

Biogen Inc. (Nasdaq: BIIB) – announced the company will present a variety of new data from its felzartamab clinical development program at Kidne...

October 23, 2024 | Wednesday | News
Novartis’ Kisqali Receives Positive CHMP Opinion for Adjuvant Treatment of High-Risk Early Breast Cancer

Novartis announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and...

October 21, 2024 | Monday | News
Eisai and Biogen Seek Reconsideration of Lecanemab Registration Decision in Australia

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusett...

October 17, 2024 | Thursday | News
Transforming Vision: Jacqueline Henderson on Johnson & Johnson's Groundbreaking IOL Innovations

As President of EMEA at Vision Johnson & Johnson, Jacqueline Henderson is at the forefront of innovation in ophthalmology, overseeing the development...

October 01, 2024 | Tuesday | Interview
IDT Pioneers CRISPR Safety and Accuracy with Advanced Technologies

  In a recent Q&A session with BioPharma BoardRoom, Gavin Kurgan, Bioinformatics Applications Development Manager at Integrated DNA Technologies ...

July 29, 2024 | Monday | Interaction
Breaking Barriers in CAR T Cell Therapy: Martin Westberg on How the Sefia Platform is Transforming Manufacturing

In this insightful interview with Martin Westberg, Vice President and General Manager of Cell Therapy at Cytiva, BioPharma BoardRoom delve into the tr...

June 06, 2024 | Thursday | Interview
Driving Global Access to Medicines: A Conversation with Cem Zorlular, CEO of Er-Kim

  In an interview with BioPharma BoardRoom, Cem Zorlular, CEO of Er-Kim, shares his personal journey and the driving force behind Er-Kim's mission to...

May 06, 2024 | Monday | Interview

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close